Cardiac dysrhythmia
Types of Arrhythmias:
1. Sinus Arrhythmias
• ANS influence SA node to change rate of firing to meet body’s demand for O2
Sinus tachycardia
• faster than normal HR with normal- appearing ECG.
Sinus bradycardia
• Slower than normal HR with normal- appearing ECG.
2. Supraventricular Arrhythmias
• arrhythmias that originate above ventricles but not in SA node.
• abnormal P wave but normal QRS complexes.
Atrial flutter
• sawtoothed –shaped P waves
• regular fast atrial depolarization
• from a single ectopic focus
Atrial fibrillation
• irregular P waves
• rapid, uncoordinated atrial depolarization
• from many ectopic foci
• bombardment of impulses at AV node transmit many impulses to ventricles
cause rapid, irregular & ineffective ventricular contraction.
3. Atrioventricular block (AV block)
• Aka heart block
• slow or lack of conduction at AV node
4. Ventricular arrhythmias
• impulses from ectopic foci that originate below AV node.
• wide & prolonged QRS complexes + T wave inversion
Ventricular Tachycardia
• several PVCs at a rapid rate.
Ventricular Fibrillation
• bizarre, irregular, distorted wave
• fatal reflects inability to contract coordinately lack/total loss of CO
lack/ no blood pumped to body or brain.
• CPR necessary.
Causes of Arrhythmias:
1. electrolyte imbalances
2. hypoxia/ anoxia
3. acidosis / accumulation of waste products
4. structural damage
5. drugs
Cardiac Action Potentials
• depolarization & repolarization of myocardial cells
5 Phases:
phase 0
• rapid depolarization caused by sodium influx.
phase 1
• initial repolarization w/c coincides with termination of Na influx.
phase 2
• plateau stage
• influx of calcium prolongs action potential
• promotes atrial & ventricular contraction
phase 3
• rapid repolarization caused by K influx
phase 4
• resting membrane potential
Antiarrhythmic Drugs
Class 1a
• slows conduction & prolongs repolarization
• Tx of lifethreatening ventricular arrhythmias
1. Procainamide
associated with drug- induced SLE
associated with severe hematologic disorders
2. Moricizine
proarrhythmic increase cardiac death
3. Quinidine
DOC for long term tx of atrial arrhythmias
4. Disopyramide
Class 1b
• slows conduction & slows repolarization
• tx of lifethreatening ventricular arrhythmias
1. Lidocaine
first line drug for ventricular ectopy
DOC for premature ventricular contractions (PVCs), ventricular tachycardia &
fibrillation , esp during MI
2. Tocainide
also used for myotonic dystrophy & trigeminal neuralgia
3. Mexiletine
Class Ic
• extreme slowing of conduction with little or no effect on repolarization.
• Tx of paroxysmal atrial tachycardia (PAT) & lifethreatening ventricular arryhtmias
1. Flecainide
proarrhythmic
2. Propafenone
DOC for PAT
1. Esmolol
DOC for short-term tx of SVT
2. Acebutolol
Tx of PVCs
3. Propanolol
Tx of SVT caused by digoxin or catecholamines
Crosses BBB
Antianginal, antihypertensive, antimigraine headache
1. Bretylium
short-term Tx of ventricular tachycardia/ fibrillation.
4. Ibutilide
DOC to rapidly convert atrial fibrillation or flutter of recent onset.
5. Dofetilide
use to convert atrial fibrillation or flutter to NSR.
maintain NSR after conversion of atrial arrhythmias.
1. Verapamil
Tx of paroxysmal SVT
slow ventricular response to atrial fibrillation/ flutter
CI in AV block & CHF
2. Diltiazem
Tx of paroxysmal SVT
Other antidysrhythmics:
1. Adenosine
DOC for tx of SVT
Including those caused by use of alternate conduction pathways
Ie. Wolff-parkinson –White syndrome.
2. Digoxin
Effective in TX of atrial arrhythmias.
1. Quinidine
• N & V , diarrhea, confusion & hypotension
• cause heartblock & psychiatric symptoms.
2. Procainamide
• less cardiac depression than quinidine
• assoc with drug-induced SLE, neutropenia, thrombocytopenia
5. Beta-blockers
• bradycardia
• hypotension
Nursing Responsibilities:
1. Obtain baseline VS & ECG.
2. Check early cardiac enzymes.(LDH, CPK, aspartate aminotransferase)
3. Administer IV push or bolus over a period of 2 - 3 min.
4. Titrate dose to the smallest amount needed.
5. Give parenteral forms only if oral form is not feasible.
6. Continuous cardiac monitoring.